Matches in Wikidata for { <http://www.wikidata.org/entity/Q37205309> ?p ?o ?g. }
- Q37205309 description "article científic" @default.
- Q37205309 description "article scientifique" @default.
- Q37205309 description "articolo scientifico" @default.
- Q37205309 description "artigo científico" @default.
- Q37205309 description "artículu científicu espublizáu en 2009" @default.
- Q37205309 description "bilimsel makale" @default.
- Q37205309 description "scientific article published on 28 June 2009" @default.
- Q37205309 description "vedecký článok" @default.
- Q37205309 description "vetenskaplig artikel" @default.
- Q37205309 description "videnskabelig artikel" @default.
- Q37205309 description "vědecký článek" @default.
- Q37205309 description "wetenschappelijk artikel" @default.
- Q37205309 description "wissenschaftlicher Artikel" @default.
- Q37205309 description "наукова стаття, опублікована в червні 2009" @default.
- Q37205309 description "научни чланак" @default.
- Q37205309 description "مقالة علمية نشرت في 28 يونيو 2009" @default.
- Q37205309 name "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 name "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 name "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 type Item @default.
- Q37205309 label "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 label "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 label "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 prefLabel "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 prefLabel "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 prefLabel "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma." @default.
- Q37205309 P1433 Q37205309-CBDEA157-3BB9-4A49-B2BC-1F7BCCCAA73F @default.
- Q37205309 P1476 Q37205309-AB87F96A-3671-4F9F-BCF3-47F70CA509AE @default.
- Q37205309 P2093 Q37205309-06298F43-AAE7-4E87-B52D-2E14CF10553D @default.
- Q37205309 P2093 Q37205309-105EA854-CAA8-4BB0-B45E-CAF6AD8D6EC4 @default.
- Q37205309 P2093 Q37205309-1828B4A5-94B5-4E2F-9064-7A4E7926A3CA @default.
- Q37205309 P2093 Q37205309-26D15625-DDDC-4510-8F78-39A203E502F6 @default.
- Q37205309 P2093 Q37205309-2D4AB55D-D25A-4DCD-B39E-8BAC1BABEDF4 @default.
- Q37205309 P2093 Q37205309-325F1E23-52BB-4448-9865-A64A8C89A061 @default.
- Q37205309 P2093 Q37205309-57F62F9E-1FB0-4FBD-A3AD-ED73C79292AC @default.
- Q37205309 P2093 Q37205309-7D2C6905-EDFD-4E42-BEB6-07BF92D70A5D @default.
- Q37205309 P2093 Q37205309-A63537C9-BFC9-4819-9DD6-6ABEAFE811C3 @default.
- Q37205309 P2093 Q37205309-B65230F8-DCE9-4887-BB0A-E363B320D7F5 @default.
- Q37205309 P2093 Q37205309-C2D5041C-F53A-4725-A79A-DFA4E33780C9 @default.
- Q37205309 P2093 Q37205309-C5BB1845-7102-489A-8491-5168CEAFF2B7 @default.
- Q37205309 P2093 Q37205309-F71C9300-7587-4CF7-B5B9-11D995429F92 @default.
- Q37205309 P2860 Q37205309-0984D965-6C2D-4F75-B8BF-ABDF3053CEDA @default.
- Q37205309 P2860 Q37205309-0C3D96A2-CA6C-44A9-A6F9-5B85388CF354 @default.
- Q37205309 P2860 Q37205309-138F6CCD-E3DF-4657-A5BD-3C1D2F46DB88 @default.
- Q37205309 P2860 Q37205309-1429DD57-1208-43A7-A77E-E7920F2D6C76 @default.
- Q37205309 P2860 Q37205309-1D67C092-5AC7-4C38-B7A9-DBFCB0F7C42A @default.
- Q37205309 P2860 Q37205309-24732F56-E7AF-41DE-BFC2-2EE4F0326739 @default.
- Q37205309 P2860 Q37205309-354A7B4C-4963-4D88-AE74-D02F949E7C12 @default.
- Q37205309 P2860 Q37205309-4A57D406-BC39-4C61-B5F8-1B1F8E105F24 @default.
- Q37205309 P2860 Q37205309-6BA60E60-52AA-4E01-993B-7E5579D7EEA9 @default.
- Q37205309 P2860 Q37205309-7A1B00FA-00E7-4736-B4EF-04B3B273D9F3 @default.
- Q37205309 P2860 Q37205309-7FDEE760-B174-40A6-8F61-08EB50374665 @default.
- Q37205309 P2860 Q37205309-85B23BA4-5072-4745-A160-390A69483EC4 @default.
- Q37205309 P2860 Q37205309-97C5C101-67D2-42D8-8D08-171A661C2C86 @default.
- Q37205309 P2860 Q37205309-9CCE427C-DCC5-4AA5-9DDE-78D04B9E17E0 @default.
- Q37205309 P2860 Q37205309-A8A36231-2B9B-46B5-A17E-2A3CDD43C89C @default.
- Q37205309 P2860 Q37205309-A963DC6B-5C3C-4996-B340-9403DC0CD26B @default.
- Q37205309 P2860 Q37205309-AFE4F5D7-5C72-4FA7-8165-F667D9D9DCD2 @default.
- Q37205309 P2860 Q37205309-B7C05146-81C8-477F-A3FE-806008E56AF0 @default.
- Q37205309 P2860 Q37205309-C49E5906-1EE3-426B-A4FC-4C6ACDF808DC @default.
- Q37205309 P2860 Q37205309-D18C35AD-C025-4CB3-AAFD-65CEAD7384A5 @default.
- Q37205309 P2860 Q37205309-D72AB90D-D1F0-4CA9-B514-C6C4B2CED297 @default.
- Q37205309 P2860 Q37205309-D9369182-8D09-4C53-B4BF-C2440D1DC5CE @default.
- Q37205309 P2860 Q37205309-E3D8A25F-8321-48DE-9927-7AFF40564093 @default.
- Q37205309 P2860 Q37205309-E5A5E251-D7D8-4F80-A9CE-D742166B4A7E @default.
- Q37205309 P2888 Q37205309-9C7A5055-0DA4-4FE1-A077-059E03C1ECA0 @default.
- Q37205309 P304 Q37205309-1267C19D-4232-4D5F-A657-42FF8456B9D0 @default.
- Q37205309 P31 Q37205309-F14E9F9E-6724-4DF2-A5CF-A50644380DE5 @default.
- Q37205309 P356 Q37205309-59C5802D-C6BB-40D3-9DBB-998D72A5CFED @default.
- Q37205309 P433 Q37205309-9D2BD87A-E4B1-47CE-892C-52D36174233F @default.
- Q37205309 P478 Q37205309-A72E146F-55E7-4583-BFB1-9926DEC3AF55 @default.
- Q37205309 P50 Q37205309-0516B97B-BA4F-4588-A909-80F49EB2F88F @default.
- Q37205309 P50 Q37205309-40570B0C-44D4-4BE4-B7EA-C482438DC012 @default.
- Q37205309 P50 Q37205309-D712C370-128B-4AA1-97B8-F0C54E16A4AC @default.
- Q37205309 P50 Q37205309-DFEE36F7-C697-428F-8823-43A95EA23A4D @default.
- Q37205309 P50 Q37205309-FA6B8312-F948-48B4-BB47-D6126F273810 @default.
- Q37205309 P577 Q37205309-6E7B7CEF-E7BB-44EA-ACDF-C6B2B741CBBD @default.
- Q37205309 P5875 Q37205309-7EDED5C6-B126-4E76-B938-E649DB81C5C6 @default.
- Q37205309 P698 Q37205309-2FFA92ED-FEFC-43D1-AB16-67BE94702238 @default.
- Q37205309 P921 Q37205309-EA99E050-2E7F-4547-8400-1C71BD018103 @default.
- Q37205309 P932 Q37205309-98F79A31-0F49-4288-8DC4-DAADD6C44722 @default.
- Q37205309 P356 S11060-009-9948-7 @default.
- Q37205309 P698 19562255 @default.
- Q37205309 P1433 Q15752119 @default.
- Q37205309 P1476 "Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma" @default.
- Q37205309 P2093 "Andrew B Lassman" @default.
- Q37205309 P2093 "Andrew D Norden" @default.
- Q37205309 P2093 "Frank Lieberman" @default.
- Q37205309 P2093 "H Ian Robins" @default.
- Q37205309 P2093 "Howard A Fine" @default.
- Q37205309 P2093 "Janet Dancey" @default.
- Q37205309 P2093 "Jeffrey J Raizer" @default.
- Q37205309 P2093 "Kathleen R Lamborn" @default.
- Q37205309 P2093 "Kenneth Aldape" @default.
- Q37205309 P2093 "Mark R Gilbert" @default.
- Q37205309 P2093 "Michael D Prados" @default.
- Q37205309 P2093 "Susan M Chang" @default.
- Q37205309 P2093 "W K Alfred Yung" @default.
- Q37205309 P2860 Q29620605 @default.
- Q37205309 P2860 Q31003450 @default.